Clinical Trial Update: Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, attenuation, and immunogenicity of the GAP3KO malaria vaccine delivered via Anopheles stephensi mosquitoes; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• GAP3KO (GAP3KO)

Snippet

Sponsor: Seattle Children's Hospital | Conditions: Malaria | Phase 1 | Status: COMPLETED